Tuesday, December 11, 2018

Key Issues

SESSION 1/CANCER POLICIES AND THE COST OF PRECENTING, RESEARCHING AND TREATING CANCER

  • Policy Initiatives and Policy Issues Associated with Cancer Prevention and Treatment
  • The role of the European Reference Networks
  • The necessity of registries for oncology in Greece
  • The economic aspect of Cancer Treatment and the benefits for the National Healthcare System
  • Propositions of Defining and Measuring Value in Cancer Care
  • Towards a National Cancer Strategy

SESSION 2/INNOVATION IN CANCER RESEARCH & TREATMENT

Keynote Speech:
The new Precision Medicine Infrastructure Project in Greece

  • Legal Framework for the use of the Innovative Therapies in Cancer Treatment
  • Assessments of Oncology drug pricing and reimbursement policies
  • Orphan Drugs &Companion Diagnostics
  • The Evolution of Clinical Trials in Oncology

SESSION 3/PERSONALISED AND TARGETED THERAPIES & THE USE OF BIOMARKERS

  • The value of Personalized Medicine and Access Problems in the Greek healthcare system
  • Access to Personalized Therapies with the use of Biomarkers
  • Liquid biopsies and the optimal use of biomarkers
  • Biomarker tests, quality criteria and accreditation of diagnostic laboratories
  • GDRP and the use of Personal Data
  • ORGANIZED BY
  • UNDER THE AUSPICES OF
  • SPONSORS
  • SUPPORTERS
MSD
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • INTERPRETATION SPONSOR
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team